Abstract
This study investigates how human mobility has changed in the long-term in response to the COVID-19-related information in Japan. We use publicly available data from Google on human mobility in retail & recreation and residential spent time. These variables can be explained using daily data on the number of infected cases, whether the state of the emergency is declared or not, and the cumulated number of the vaccinated person. In the regression analysis, we use the ‘interactive effects model’ to control complicated unobservable factors that vary across time and cross-sectional dimensions. Our regression results find that people feared an unknown virus in the 1st wave, but the habituation trend for human mobility is noticed for the repeated similar infection information. However, from a different kind of information about the spread of new variants, people’s habituation comes to a halt to some extent. Further, the spatial interaction of infection information is observed. We also show that people reacted to infection information even without a state of emergency declaration. Also, vaccination promotion encourages people to go out with security. When implementing policies to control human mobility, it is essential to consider the timing, and the degree of information penetration, carefully.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated during and/or analysed during the current study are available from the author on reasonable request.
